Non Animal Testing, Alternative Test Methods, In Vitro Toxicology, IIVS |

06 Oct Video: The 3T3 Neutral Red Uptake Phototoxicity Test – Spanish

Posted at 19:48h in Uncategorized by Jane Ryan 0 Comments

1 Like

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css=""]Oct 6, 2017 This new training video explores a cell-based method for assessing Phototoxicity — or the potential for chemicals to cause damage after being exposed to light. The method is used widely around the world by many...

07 Sep Chinese FDA and IIVS Re-affirm Their Collaboration for Non-animal Tests

Posted at 15:12h in Uncategorized by Jane Ryan 0 Comments

0 Likes

GAITHERSBURG, MD – Sept. 7, 2017 – Bo Li, General Director of the CFDA’s National Institute for Food and Drug Control (NIFDC) and Erin Hill, President of US based non-profit, Institute for In Vitro Sciences, Inc. (IIVS), signed a Memorandum of Understanding (MOU) to bring...

28 Aug Quality Considerations: Redefining Test Systems from Animals to Tissues and Beyond

Posted at 17:12h in Uncategorized by Jane Ryan 0 Comments

3 Likes

The use of non-whole animal test methods transforms the way regulatory requirements are applied in preclinical testing. Recent global regulatory initiatives emphasize the importance of transitioning to human relevant assays and test systems that do not use animals. When these methods are moved from research...

28 Aug Introducing the 3R Concepts into Pre-College Classrooms

Posted at 17:04h in Uncategorized by Jane Ryan 0 Comments

3 Likes

This poster provides a snapshot of pre-college teachers (46) within the U.S.—gauging their knowledge and familiarity of the 3Rs and non-animal testing methods (i.e. in vitro methods), initiative to address the topic in the classroom, and their students’ level of interest in the topic. While...

28 Aug Non-Animal Testing Approach to Address Biocompatibility Testing of Medical Devices Required by the United States Food and Drug Administration (US FDA)

Posted at 16:54h in Uncategorized by Jane Ryan 0 Comments

6 Likes

Presented at the 2017 World Congress on Alternatives and Animals in the Life Sciences (WC10) E. Hill, R. Curren, and G.-E. Costin Starting in December 2015, personal lubricants must receive pre-market approval from the US FDA Center for Devices and Radiological Health (CDRH) in order to be sold...

23 Aug Collaborative Effort Aims to Replace Rabbit Test for Personal Lubricant Products

Posted at 19:27h in Uncategorized by Jane Ryan 0 Comments

1 Like

Washington, D.C. — August 21, 2017 — A first-of-its kind collaborative project is underway to find a non-animal test method to replace the rabbit vaginal irritation test for personal lubricants. The U.S. Food and Drug Administration (FDA) gave the project a green light as part...

23 Aug Observation Spots Available for 2018 Practical Methods Workshop

Posted at 19:16h in Uncategorized by Jane Ryan 0 Comments

1 Like

It's not too late to register for the 2018 Practical Methods in In Vitro Toxicology Workshop, Jan,16-19, at IIVS in Gaithersburg, MD. Observation spots are available for the intensive four-day workshop. Gain the scientific information and expertise you need to strategically integrate non-animal methods within...

21 Aug Collaborative Effort Aims to Replace Rabbit Test for Personal Lubricant Products

Posted at 15:38h in Uncategorized by Jane Ryan 0 Comments

0 Likes

Study in Response to Consumer Demands for Humane Testing Washington, D.C. — August 21, 2017 — A first-of-its kind collaborative project is underway to find a non-animal test method to replace the rabbit vaginal irritation test for personal lubricants. The U.S. Food and Drug Administration (FDA)...

17 Aug In Vitro Exposure Systems and Dosimetry Assessment Tools for Inhaled Tobacco Products: Workshop Proceedings, Conclusions and Paths Forward for In Vitro Model Use

Posted at 17:07h in Uncategorized by Jane Ryan 0 Comments

5 Likes

In 2009, the passing of the Family Smoking Prevention and Tobacco Control Act facilitated the establishment of the FDA Center for Tobacco Products (CTP), and gave it regulatory authority over the marketing, manufacture and distribution of tobacco products, including those termed ‘modified risk’. On April...

27 Jul IIVS e-News – August 2017

Posted at 14:03h in Uncategorized by Jane Ryan 0 Comments

4 Likes